FY2024 EPS Estimates for CVS Health Lowered by Analyst

CVS Health Co. (NYSE:CVSFree Report) – Leerink Partnrs dropped their FY2024 EPS estimates for CVS Health in a report released on Monday, January 27th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will earn $5.16 per share for the year, down from their prior forecast of $5.21. The consensus estimate for CVS Health’s current full-year earnings is $5.22 per share. Leerink Partnrs also issued estimates for CVS Health’s Q4 2024 earnings at $0.94 EPS, Q1 2025 earnings at $1.20 EPS, Q2 2025 earnings at $1.58 EPS, Q3 2025 earnings at $1.67 EPS, Q4 2025 earnings at $1.32 EPS, FY2025 earnings at $5.77 EPS and FY2026 earnings at $7.10 EPS.

CVS Health (NYSE:CVSGet Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 EPS.

Other equities analysts also recently issued research reports about the stock. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Evercore ISI boosted their price target on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Finally, Piper Sandler reduced their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

View Our Latest Research Report on CVS

CVS Health Stock Down 0.6 %

NYSE CVS opened at $57.00 on Tuesday. CVS Health has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock has a market cap of $71.73 billion, a PE ratio of 14.47, a P/E/G ratio of 0.80 and a beta of 0.59. The stock’s 50 day moving average is $51.27 and its 200 day moving average is $56.18.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.67%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health during the third quarter worth approximately $25,000. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health during the third quarter worth $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health during the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the 3rd quarter worth about $33,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Company Profile

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Further Reading

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.